LIF SE’s Directors, Carlos Arques, Guillermo Cleti and the General Manager Roberto Ganin, visited the Laboratorio de Hemoderivados (LH), in which Universidad Nacional de Córdoba (UNC) has full ownership.
LH are specialists in medicines production through plasma derivatives (products manufactured from human plasma by plasma fractionation techniques).
Also, LH produces injection medicines apart from non-plasma derivatives.
THE Directors met with the main authorities Catalina Massa (Executive Director), Ada María Sisti (Technical Director), Cristian Moya (Production Manager) and Daniel Sabena (Marketing Manager).
LIF’s staff members worked on an agreement between LIF and LH to produce some of these injections for the Health Public System of Santa Fe.
